Bevacizumab Biosimilar: Emerging Trends and Opportunities 2025-2033
The competitive landscape is vibrant, with key players actively introducing new biosimilars and forming strategic partnerships to enhance distribution and reduce prices. This growth not only represents a significant shift in cancer treatment but also promises to improve patient care worldwide.